Skip to Main Content

Paper Details

Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea.
Cancer Res Treat
24
2017
Glioblastoma, MGMT, MGMT promoter, O6-methylguanine, O6-methylguanine-DNA methyltransferase, Patients, TMZ, Temozolomide, glioblastoma multiforme, patients, temozolomide
Author NameAffiliation
Byung Sup KimKosin University Gospel Hospital, Kosin University College of Medicine
Ho Jun SeolSamsung Medical Center, Sungkyunkwan University School of Medicine
Ho Jun SeolSamsung Medical Center, Sungkyunkwan University School of Medicine
Do-Hyun NamSamsung Medical Center, Sungkyunkwan University School of Medicine
Do-Hyun NamSamsung Medical Center, Sungkyunkwan University School of Medicine
Chul-Kee ParkSeoul National University Hospital, Seoul National University College of Medicine
Heon YooDepartment of Neuro-Oncology Clinic, Center for Specific Organs Cancer, National Cancer Center Hospital, National Cancer Center
Eun Young KimInha University Hospital, Inha University School of Medicine
Ho-Shin GwakNational Cancer Center
  • 1 - 9

Datasets

Release 1.2